Auf dieser Seite
MCRB Seres Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$2,94
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,8352-Wochen-Tief
$29,9852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$29M
P/E (TTM)
-1.2
EPS (TTM)
$-2.45
Umsatz (TTM)
$2M
Ihre Abzeichen
52W-Spanne
$3–$30
Analystenbewertung
BUY
Kursziel
$17
P/E
-1.2
ROE
-66.6%
Nettogewinnmarge
-1192.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
MCRB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.94
Marktkapitalisierung (MRQ)
$29M
P/E (TTM)
-1.2
EPS (TTM)
$-2.45
Umsatz (TTM)
$2M
ROE (TTM)
-66.6%
52W-Spanne
$3–$30
MCRB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 22. April 2025 | 1-for-20 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$789.0K2016-12-31 → 2025-12-31
EPS$0.642020-12-31 → 2025-12-31
Freier Cashflow$865.0K2016-12-31 → 2025-12-31
Nettogewinnmarge-1192.9%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | MCRB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.25-Jahres-Durchschnitt ≈-64.5 | ≈-64.5 | · | · | |
| P/S (TTM) | 15.35-Jahres-Durchschnitt ≈751.1 | ≈751.1 | 79.9 | Unterbewertet | |
| K/B (MRQ) | 0.85-Jahres-Durchschnitt ≈308.9 | ≈308.9 | 2.2 | Überbewertet | |
| Kurs / FCF (TTM) | -0.65-Jahres-Durchschnitt ≈-1052.6 | ≈-1052.6 | · | · | |
| Kurs / Cashflow (TTM) | -0.65-Jahres-Durchschnitt ≈460.7 | ≈460.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.65-Jahres-Durchschnitt ≈407.2 | ≈407.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | MCRB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -4462.8%5-Jahres-Durchschnitt ≈-3874.5% | ≈-3874.5% | -5293.3% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -4279.6%5-Jahres-Durchschnitt ≈-3718.1% | ≈-3718.1% | -5247.7% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -1192.9%5-Jahres-Durchschnitt ≈-730.7% | ≈-730.7% | -4906.2% | Spitzenklasse | |
| ROA (TTM) | -18.3%5-Jahres-Durchschnitt ≈-23.6% | ≈-23.6% | -40.8% | Spitzenklasse | |
| ROE (TTM) | -66.6%5-Jahres-Durchschnitt ≈-57.3% | ≈-57.3% | -107.8% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | MCRB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.15-Jahres-Durchschnitt ≈2.2 | ≈2.2 | 2.0 | Im Einklang | |
| Quick Ratio | 2.45-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 0.8 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | MCRB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -52.0% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -52.7% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 4088.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | MCRB | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.0 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 10.1 | · | 6.6 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$12.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-49.6%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $1.07 | $-2.23 | 148.0% |
| 31. März 2026 | $-2.08 | $-1.92 | -8.5% | |
| 31. Dezember 2025 | $-1.78 | $-2.15 | 17.3% | |
| 30. September 2025 | $0.94 | $1.31 | -28.0% | |
| 30. Juni 2025 | $-2.27 | $-2.54 | 10.7% | |
| 31. März 2025 | $-2.96 | $-0.55 | -437.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| R&D Expense | $49M | $65M | $118M | $110M | $142M | $91M | $80M | $96M | $89M | $82M | $38M | |
| SG&A Expense | $39M | $53M | $78M | $70M | $69M | $31M | $25M | $33M | $34M | $33M | $17M | |
| Operating Expenses | $95M | $121M | $195M | $180M | $209M | $121M | $106M | $129M | $123M | $115M | $55M | |
| Operating Income | $-94M | $-121M | $-195M | $-180M | $-64M | $-88M | $-72M | $-100M | $-91M | $-93M | $-55M | |
| Interest Income | $2M | $4M | $7M | $3M | $3M | $946.0K | $1M | $1M | $2M | · | · | |
| Other Non-op | $17M | $-14M | $134.0K | $-705.0K | $-1M | $981.0K | $1M | $1M | $2M | $1M | $76.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| EPS (Basic) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| EPS (Diluted) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · | |
| Shares (Basic) | 8,858,975 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| Shares (Diluted) | 8,869,742 | 7,769,910 | 6,400,339 | 108,077,043 | 91,702,866 | 79,789,220 | · | · | · | · | · | |
| EBITDA | $-90M | $-116M | $-102M | $-240M | $-59M | $-82M | $-64M | $-92M | $-84M | $-89M | $-54M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $31M | $128M | $163M | $180M | $116M | $65M | $86M | $36M | $55M | $74M | |
| Short-term Investments | · | · | $0 | $18M | $111M | $138M | $30M | · | $114M | $139M | $131M | |
| Receivables | $157.0K | $0 | · | · | · | $9M | $2M | · | · | · | · | |
| Inventory | · | · | $30M | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $6M | $8M | $13M | $13M | $6M | $4M | $7M | $5M | $5M | $3M | |
| Current Assets | $49M | $39M | $175M | $195M | $304M | $269M | $100M | $93M | $155M | $198M | $208M | |
| PP&E (Net) | $8M | $12M | $18M | $23M | $18M | $14M | $19M | $26M | $33M | $36M | $8M | |
| PP&E (Gross) | $64M | $65M | $67M | $68M | $58M | $48M | $47M | $47M | $45M | $41M | $9M | |
| Accum. Depreciation | $57M | $53M | $49M | $45M | $40M | $34M | $28M | $20M | $12M | $5M | $1M | |
| Other Non-current Assets | $31.0K | $31.0K | $2M | $10M | $5M | · | · | · | · | · | · | |
| Total Assets | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Accounts Payable | $2M | $4M | $4M | $17M | $14M | $4M | $5M | $6M | $7M | $8M | $5M | |
| Short-term Debt | · | · | $0 | $456.0K | $0 | $454.0K | · | · | · | · | · | |
| Current Liabilities | $19M | $41M | $99M | $86M | $82M | $46M | $46M | $42M | $32M | $30M | $11M | |
| Capital Leases | $73M | $83M | $92M | $108M | $18M | $11M | $16M | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $11M | $1M | $502.0K | $644.0K | $1M | · | · | |
| Total Liabilities | $94M | $126M | $403M | $338M | $223M | $168M | $181M | $169M | $129M | $140M | $12M | |
| Long-term Debt | · | · | $110M | $50M | $24M | $25M | $25M | · | · | · | · | |
| Total Debt | · | · | $0 | $456.0K | · | $454.0K | · | · | · | · | · | |
| Common Stock | $10.0K | $9.0K | $135.0K | $125.0K | $92.0K | $91.0K | $70.0K | $41.0K | $40.0K | $40.0K | $39.0K | |
| Retained Earnings | $-972M | $-978M | $-978M | $-865M | $-614M | $-549M | $-460M | $-389M | $-264M | $-174M | $-83M | |
| AOCI | · | $0 | $0 | $-12.0K | $-60.0K | $-47.0K | · | · | $-146.0K | $-149.0K | $30.0K | |
| Stockholders' Equity | $44M | $14M | $-45M | $11M | $132M | $175M | $-48M | $-48M | $61M | $133M | $205M | |
| Liabilities + Equity | $138M | $140M | $359M | $349M | $355M | $343M | $132M | $120M | $190M | $273M | $217M | |
| Shares Outstanding | 9,556,466 | 8,650,227 | 6,752,073 | 6,261,400 | 91,889,418 | 91,459,239 | 70,143,252 | 40,936,735 | 40,571,015 | 40,355,753 | 39,082,017 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $5M | $6M | $7M | $6M | $7M | $8M | $8M | $7M | $4M | $728.0K | |
| Stock-based Comp | $11M | $21M | $34M | $25M | $20M | $9M | $8M | $17M | $17M | $17M | $10M | |
| Restructuring | $1M | · | $6M | · | $0 | $0 | $1M | $0 | $0 | · | · | |
| Other Non-cash | $-20M | $-175M | $-44M | $-11M | $46M | $-20M | $-22M | $12M | $-11M | $114M | $4M | |
| Operating Cash Flow | $1M | $-149M | $-117M | $-229M | $7M | $-94M | $-77M | $-63M | $-76M | $44M | $-41M | |
| CapEx | $252.0K | $380.0K | $8M | $10M | $10M | $591.0K | $1M | $2M | $5M | $21M | $4M | |
| Investing Cash Flow | $-42.0K | $142M | $11M | $82M | $64M | $-159M | $-31M | $112M | $56M | $-66M | · | |
| Debt Issued | · | · | · | $28M | $0 | $0 | $25M | · | · | · | · | |
| Net Debt Issued | · | · | · | $28M | · | · | $25M | · | · | · | · | |
| Stock Issued | · | $0 | $0 | $97M | $0 | $244M | $61M | · | · | · | $143M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Net Stock Activity | · | $0 | $0 | $97M | · | $244M | $61M | · | $-33.0K | · | $143M | |
| Financing Cash Flow | $14M | $-90M | $72M | $130M | $1M | $303M | $86M | $268.0K | $83.0K | $2M | · | |
| Net Change in Cash | · | · | · | · | · | $51M | $-21M | $50M | $-20M | $-20M | $-40M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $865.0K | $-149M | $-125M | $-239M | $-3M | $-94M | $-78M | $-65M | $-80M | $22M | $-45M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11910.1% | · | -85.5% | -3458.1% | -44.5% | -265.3% | -208.3% | -354.8% | -284.7% | -426.5% | · | |
| Net Margin | 721.9% | · | -90.0% | -3509.5% | -45.2% | -268.3% | -203.7% | -350.0% | -278.4% | -420.7% | · | |
| EBITDA Margin | -11386.3% | · | -80.5% | -3365.1% | -40.4% | -245.5% | -186.3% | -327.0% | -262.1% | -407.2% | · | |
| ROA | 4.1% | 0.05% | -32.1% | -71.1% | -18.8% | -37.5% | -55.6% | -63.8% | -38.7% | -37.4% | -32.8% | |
| ROE | 14.8% | 0.72% | 379.2% | -638.4% | -42.7% | -49.1% | 174.5% | 251.7% | -92.5% | -54.2% | -61.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 | 5.8 | 2.2 | 2.2 | 4.9 | 6.5 | 19.0 | |
| Quick Ratio | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 | 5.7 | 1.5 | 2.0 | 4.7 | 6.3 | 18.8 | |
| Debt / Equity | · | · | 0.0 | 0.0 | · | 0.0 | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.4 | 0.0 | 0.4 | 0.1 | 0.3 | 0.2 | 0.1 | 0.1 | 0.0 | |
| Receivables Turnover | 10.1 | · | · | · | · | 5.9 | 38.7 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.63 | $0.08 | $-0.33 | $0.09 | $1.43 | $1.91 | $-0.69 | $-1.17 | $1.50 | $3.29 | $5.26 | |
| Revenue / Share | $0.09 | · | $0.99 | $0.07 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.13 | $-0.96 | $-0.92 | $-2.12 | · | · | · | · | · | · | · | |
| Cash / Share | $4.79 | $0.18 | $0.95 | $1.30 | $1.96 | $1.27 | $0.93 | $2.10 | $0.89 | $1.35 | $1.89 | |
| EPS (TTM) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -95.1% | 336.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -52.0% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -52.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 4088.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $789.0K | $0 | $0 | $7M | $145M | $33M | $35M | $28M | $32M | $22M | $0 | |
| Net Income TTM | $6M | $136.0K | $-114M | $-250M | $-66M | $-89M | $-70M | $-99M | $-89M | $-92M | $-55M | |
| Market Cap | $142M | $2.88B | $3.78B | $14.02B | $15.31B | $44.82B | $4.84B | $3.70B | $8.23B | $7.99B | $27.43B | |
| Enterprise Value | · | · | $3.65B | $13.84B | · | $44.56B | · | · | · | · | · | |
| P/E | 23.2 | · | -1.6 | -48.5 | -231.4 | -437.5 | · | · | · | · | · | |
| P/S | 180.2 | · | · | 1967.6 | 105.6 | 1349.2 | 140.3 | 130.9 | 256.3 | 367.1 | · | |
| P/B | 3.2 | 208.6 | -84.3 | 1300.6 | 116.4 | 256.5 | -100.2 | -77.0 | 135.6 | 60.2 | 133.5 | |
| P / Tangible Book | 3.2 | 208.6 | · | 1300.6 | 116.4 | 256.5 | · | · | · | · | · | |
| P / Cash Flow | 127.3 | -19.3 | -32.2 | -61.3 | 2289.0 | -478.7 | -63.2 | -58.9 | -108.9 | 181.9 | -671.5 | |
| P / FCF | 164.4 | -19.3 | -30.2 | -58.8 | -5319.2 | -475.7 | -62.4 | -57.1 | -102.6 | 356.3 | -606.7 | |
| EV / EBITDA | · | · | -35.9 | -57.7 | · | -546.4 | · | · | · | · | · | |
| EV / FCF | · | · | -29.1 | -58.0 | · | -473.1 | · | · | · | · | · | |
| EV / Revenue | · | · | · | 1942.2 | · | 1341.6 | · | · | · | · | · | |
| Earnings Yield | 4.3% | 0.00% | -63.5% | -2.1% | -0.43% | -0.23% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $736.0K | $358.0K | $438.0K | $351.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-126M | $310.0K | $126M | $-522.0K | · | $3M | |
| R&D Expense | $9M | $13M | $12M | $13M | $13M | $12M | $13M | $16M | $16M | $19M | $2M | $25M | $47M | $44M | $-17M | $43M | |
| SG&A Expense | $7M | $8M | $8M | $9M | $10M | $12M | $12M | $13M | $13M | $15M | $8M | $19M | $28M | $22M | $13M | $18M | |
| Operating Expenses | $22M | $21M | $20M | $23M | $25M | $27M | $29M | $29M | $29M | $34M | $4M | $45M | $77M | $70M | $-4M | $63M | |
| Operating Income | $-21M | $-21M | $-19M | $-22M | $-25M | $-27M | $-29M | $-29M | $-29M | $-34M | $-129M | $-45M | $50M | $-71M | $-2M | $-59M | |
| Interest Income | $181.0K | $325.0K | $445.0K | $618.0K | $546.0K | $618.0K | $437.0K | $652.0K | $1M | $2M | $2M | $3M | $2M | $1M | $1M | $865.0K | |
| Other Non-op | $673.0K | $669.0K | $2M | $3M | $4M | $7M | $6M | $-23M | $1M | $505.0K | $336.0K | $999.0K | $-2M | $310.0K | $-23.0K | $-33.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $5M | $-20M | $-15M | $8M | $-20M | $33M | $-16M | $89M | $-33M | $-40M | $-41M | $-48M | $47M | $-71M | $-69M | $-60M | |
| EPS (Basic) | $0.47 | $-2.08 | $-1.79 | $0.94 | $-2.27 | $3.76 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| EPS (Diluted) | $0.47 | $-2.08 | $-1.78 | $0.94 | $-2.27 | $3.75 | $-1.80 | $11.63 | $-4.34 | $-5.49 | $-17.19 | $-0.37 | $0.36 | $-0.57 | $-0.51 | $-0.49 | |
| Shares (Basic) | 9,706,193 | 9,582,533 | · | 8,758,692 | 8,743,733 | 8,703,221 | · | 7,632,242 | 7,575,620 | 7,305,026 | · | 128,289,871 | 127,713,486 | 125,862,975 | · | 122,527,275 | |
| Shares (Diluted) | 9,747,138 | 9,582,533 | · | 8,771,519 | 8,743,733 | 8,714,701 | · | 7,632,242 | 7,575,620 | 7,305,026 | · | 128,289,871 | 129,844,931 | 125,862,975 | · | 122,527,275 | |
| EBITDA | $-21M | $-20M | · | $-21M | $-24M | $-26M | · | $-28M | $-30M | $-38M | · | $-46M | $51M | $-69M | · | $-57M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $30M | $46M | $48M | $45M | $59M | $31M | $67M | $71M | $111M | · | $170M | $230M | $95M | · | $205M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $28M | |
| Receivables | $274.0K | $233.0K | $157.0K | $351.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | $53M | $42M | · | $19M | $5M | · | · | · | |
| Prepaid Expense | $1M | $2M | $3M | $3M | $2M | $4M | $6M | $6M | $6M | $5M | · | $9M | $9M | $10M | · | $15M | |
| Current Assets | $42M | $32M | $49M | $52M | $49M | $66M | $39M | $73M | $149M | $165M | · | $214M | $251M | $116M | · | $248M | |
| PP&E (Net) | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $18M | $19M | · | $24M | $24M | $24M | · | $19M | |
| PP&E (Gross) | $61M | $64M | $64M | $65M | $65M | $65M | $65M | $65M | $72M | $72M | · | $73M | $72M | $71M | · | $65M | |
| Accum. Depreciation | $55M | $57M | $57M | $56M | $55M | $54M | $53M | $52M | $54M | $52M | · | $50M | $48M | $46M | · | $45M | |
| Other Non-current Assets | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $465.0K | $42M | $41M | · | $12M | $11M | $11M | · | $12M | |
| Total Assets | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Accounts Payable | $1M | $2M | $2M | $2M | $2M | $2M | $4M | $8M | $5M | $5M | · | $9M | $13M | $12M | · | $10M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Current Liabilities | $20M | $19M | $19M | $22M | $31M | $31M | $41M | $65M | $108M | $98M | · | $79M | $78M | $64M | · | $82M | |
| Capital Leases | $45M | $70M | $73M | $75M | $78M | $80M | $83M | $85M | $101M | $103M | · | $105M | $107M | $107M | · | $18M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $961.0K | |
| Total Liabilities | $67M | $91M | $94M | $100M | $111M | $114M | $126M | $155M | $409M | $401M | · | $383M | $384M | $318M | · | $244M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $110M | $110M | · | $110M | $110M | $50M | · | $50M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Common Stock | $10.0K | $10.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $170.0K | $152.0K | $151.0K | · | $129.0K | $128.0K | $127.0K | · | $124.0K | |
| Retained Earnings | $-988M | $-992M | $-972M | $-957M | $-965M | $-945M | $-978M | $-962M | $-1.05B | $-1.02B | · | $-937M | $-889M | $-936M | · | $-796M | |
| AOCI | · | · | · | $0 | $0 | · | · | $0 | $0 | $0 | · | $0 | $-1.0K | $2.0K | · | $-118.0K | |
| Stockholders' Equity | $35M | $26M | $44M | $44M | $33M | $50M | $14M | $24M | $-87M | $-60M | $-45M | $-15M | $23M | $-48M | $11M | $68M | |
| Liabilities + Equity | $102M | $118M | $138M | $143M | $144M | $164M | $140M | $179M | $322M | $341M | · | $368M | $406M | $270M | · | $312M | |
| Shares Outstanding | 9,827,569 | 9,592,326 | 9,556,446 | 8,764,664 | 8,754,482 | 8,732,187 | 8,650,227 | 170,200,253 | 151,633,922 | 151,442,034 | 6,752,073 | 128,630,689 | 128,037,679 | 126,592,604 | 125,222,273 | 124,410,917 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $670.0K | $781.0K | $954.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | |
| Stock-based Comp | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $5M | $9M | $13M | $7M | $7M | $6M | |
| Restructuring | $0 | $914.0K | $0 | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $1M | · | · | · | $-10M | · | · | · | $-3M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-22M | $-16M | $-15M | $2M | $-13M | $27M | $-39M | $-35M | $-40M | $-35M | $-47M | $-59M | $66M | $-77M | $-53M | $-60M | |
| CapEx | $0 | $0 | $29.0K | $8.0K | $181.0K | $34.0K | $90.0K | $129.0K | $99.0K | $62.0K | $877.0K | $2M | $1M | $4M | $3M | $1M | |
| Investing Cash Flow | $14.0K | $0 | $181.0K | $-8.0K | $-181.0K | $-34.0K | $-90.0K | $141M | $1M | $-62.0K | $-877.0K | $-2M | $11M | $3M | $6M | $40M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | |
| Financing Cash Flow | $2M | $428.0K | $13M | $61.0K | $0 | $1M | $2M | $-111M | $0 | $19M | $6M | $1M | $58M | $6M | $5M | $98M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $135M | $-68M | · | $79M | |
| Free Cash Flow | · | $-16M | · | · | · | $27M | · | · | · | $-35M | · | · | · | $-81M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2890.3% | -5839.9% | · | -6403.7% | · | · | · | · | · | · | · | -15294.5% | 39.2% | 13518.8% | · | -1716.2% | |
| Net Margin | 622.4% | -5562.3% | · | 2337.3% | · | · | · | · | · | · | · | -15436.8% | 36.8% | 13634.9% | · | -1742.2% | |
| EBITDA Margin | -2799.3% | -5621.8% | · | -6106.3% | · | · | · | · | · | · | · | -14751.3% | 40.4% | 13250.6% | · | -1665.5% | |
| ROA | 3.7% | -14.1% | · | 5.1% | -8.5% | 12.9% | · | 32.5% | -9.0% | -13.1% | · | -14.1% | 13.7% | -24.1% | · | -17.0% | |
| ROE | 13.6% | -51.7% | · | 24.3% | 73.4% | -704.9% | · | 2018.6% | 102.0% | 74.6% | · | -182.4% | 203.8% | -430.2% | · | -49.3% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.6 | · | 2.3 | 1.6 | 2.1 | · | 1.1 | 1.4 | 1.7 | · | 2.7 | 3.2 | 1.8 | · | 3.0 | |
| Quick Ratio | 0.8 | 1.6 | · | 2.1 | 1.5 | 1.9 | · | 1.0 | 0.7 | 1.1 | · | 2.1 | 2.9 | 1.7 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.4 | -0.0 | · | 0.0 | |
| Receivables Turnover | 1.0 | 0.3 | · | 0.4 | · | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.51 | $2.76 | · | $4.99 | $3.76 | $5.78 | · | $0.14 | $-0.57 | $-0.39 | · | $-0.12 | $0.18 | $-0.38 | · | $0.54 | |
| Revenue / Share | $0.08 | $0.04 | · | $0.04 | · | · | · | · | $0.00 | $0.00 | · | $0.00 | $0.97 | $-0.00 | · | $0.03 | |
| Cash Flow / Share | · | $-1.71 | · | · | · | $3.09 | · | · | · | $-0.24 | · | · | · | $-0.61 | · | · | |
| Cash / Share | $1.59 | $3.11 | · | $5.44 | $5.18 | $6.74 | · | $0.39 | $0.47 | $0.73 | · | $1.32 | $1.79 | $0.75 | · | $1.65 | |
| EPS (TTM) | $-2.45 | $-5.19 | · | $0.62 | $11.31 | $9.24 | · | $-15.39 | $-27.39 | $-22.69 | · | $-1.09 | $-1.21 | $-2.27 | · | $-2.35 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $1M | · | $351.0K | $0 | $0 | · | $-126M | $-126M | $522.0K | · | · | · | · | · | $13M | |
| Net Income TTM | $-22M | $-47M | · | $5M | $86M | $73M | · | $-25M | $-162M | $-83M | · | $-141M | $-153M | $-265M | · | $-231M | |
| Market Cap | $78M | $85M | · | $169M | $97M | $122M | · | $3.22B | $2.20B | $2.34B | · | $6.12B | $12.27B | $14.36B | · | $15.97B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.95B | $12.04B | $14.25B | · | · | |
| P/E | -3.2 | -1.7 | · | 31.0 | 1.0 | 1.5 | · | -1.2 | -0.5 | -0.7 | · | -43.7 | -79.2 | -50.0 | · | -54.6 | |
| P/S | 41.2 | 74.2 | · | 480.4 | · | · | · | -25.5 | -17.4 | 4491.0 | · | · | · | · | · | 1194.4 | |
| P/B | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | -25.2 | -39.2 | · | -404.9 | 542.4 | -299.9 | · | 236.4 | |
| P / Tangible Book | 2.2 | 3.2 | · | 3.9 | 3.0 | 2.4 | · | 134.6 | · | · | · | · | 542.4 | · | · | 236.4 | |
| P / Cash Flow | · | -5.2 | · | · | · | 4.5 | · | · | · | -66.5 | · | · | · | -187.4 | · | · | |
| Earnings Yield | -31.1% | -58.5% | · | 3.2% | 101.8% | 66.0% | · | -81.3% | -189.2% | -146.6% | · | -2.3% | -1.3% | -2.0% | · | -1.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $789.0K | $0 | $0 | $7M | $145M |
| Betriebsgewinnmarge % | -11910.1% | · | -85.5% | -3458.1% | -44.5% |
| Nettoergebnis | $6M | $136.0K | $-114M | $-250M | $-66M |
| Verwässerte EPS | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | 0.0 | · |
| Liquiditätsgrad | 2.6 | 0.9 | 1.8 | 2.3 | 3.7 |
| Quick Ratio | 2.4 | 0.7 | 1.3 | 2.1 | 3.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $865.0K | $-149M | $-125M | $-239M | $-3M |
Institutionelle Eigentümer (13F) 41 Einreicher · $18.2M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
41
Gehaltener Wert
$18.2M
Neue Positionen
8
Geschlossene Positionen
5
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 8 (+2 vs. Vorquartal) | 5 (-2 vs. Vorquartal) | 7 (-3 vs. Vorquartal) | 14 (+3 vs. Vorquartal) | -84K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4.824.304 | 324.214 | 26,48% | Aktien |
| Flagship Pioneering, LLC | $3.334.654 | 422.643 | 18,30% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.270.553 | 287.776 | 12,46% | Aktien |
| MARSHALL WACE, LLP | $1.359.016 | 172.245 | 7,46% | Aktien |
| Vontobel Holding Ltd. | $970.273 | 122.975 | 5,32% | Aktien |
| BlackRock, Inc. | $875.790 | 111.000 | 4,81% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $631.301 | 79.974 | 3,46% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $503.382 | 63.800 | 2,76% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $460.208 | 58.328 | 2,53% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $384.125 | 48.685 | 2,11% | Aktien |
| CITADEL ADVISORS LLC | $343.215 | 43.500 | 1,88% | Verkaufsoption |
| HAP Trading, LLC | $334.750 | 125.000 | 1,84% | Kaufoption |
| STATE STREET CORP | $267.479 | 33.901 | 1,47% | Aktien |
| Lion Point Capital, LP | $249.087 | 31.570 | 1,37% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $244.977 | 31.049 | 1,34% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $223.390 | 28.313 | 1,23% | Aktien |
| XTX Topco Ltd | $163.575 | 20.732 | 0,90% | Aktien |
| GOLDMAN SACHS GROUP INC | $120.157 | 15.229 | 0,66% | Aktien |
| NORTHERN TRUST CORP | $116.496 | 14.765 | 0,64% | Aktien |
| Invesco Ltd. | $102.365 | 12.974 | 0,56% | Aktien |
| MORGAN STANLEY | $95.769 | 12.138 | 0,53% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87.579 | 11.100 | 0,48% | Kaufoption |
| CITADEL ADVISORS LLC | $82.877 | 10.504 | 0,45% | Aktien |
| SIMPLEX TRADING, LLC | $36.278 | 4.598 | 0,20% | Aktien |
| SBI Securities Co., Ltd. | $32.996 | 4.182 | 0,18% | Aktien |
| GROUP ONE TRADING LLC | $29.303 | 3.714 | 0,16% | Aktien |
| JPMORGAN CHASE & CO | $28.325 | 3.636 | 0,16% | Aktien |
| Vanguard Global Advisers, LLC | $15.583 | 1.975 | 0,09% | Aktien |
| FMR LLC | $12.056 | 1.528 | 0,07% | Aktien |
| Rachor Investment Advisory Services, LLC | $11.654 | 1.477 | 0,06% | Aktien |
| UBS Group AG | $3.818 | 484 | 0,02% | Aktien |
| Tower Research Capital LLC (TRC) | $2.493 | 316 | 0,01% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.665 | 211 | 0,01% | Aktien |
| BARCLAYS PLC | $1.318 | 167 | 0,01% | Aktien |
| Continuum Advisory, LLC | $371 | 47 | 0,00% | Aktien |
| Sandy Spring Bank | $242 | 345 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $79 | 10 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $63 | 8 | 0,00% | Aktien |
| Larson Financial Group LLC | $39 | 5 | 0,00% | Aktien |
| WHITTIER TRUST CO OF NEVADA INC | $8 | 1 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 11 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nestlé S.A., Société des Produits Nestlé S.A. | 2. Oktober 2024 | · | Erste Einreichung | · | SEC |
| Nestle Health Science US Holdings, Inc., NIMCO US, Inc., Nestlé S.A., Nestlé US Holdco, Inc., Société des Produits Nestlé S.A. ×2 Einreichungen | 22. Juli 2022 | · | Erste Einreichung | · | SEC |
| Flagship VentureLabs IV, LLC (2), Flagship Ventures Fund IV, L.P. (2), Flagship Ventures Fund IV-Rx, L.P. (2), Flagship Ventures Fund IV General Partner LLC (2), Nutritional Health LTP Fund, L.P. (2), Nutritional Health LTP Fund General Partner LLC (2), Flagship Pioneering Fund VI, L.P. (2), Flagship Pioneering Fund VI General Partner LLC (2), Flagship Pioneering Fund VII, L.P. (2), Flagship Pioneering Fund VII General Partner LLC (2), Flagship Pioneering, Inc. (2), Noubar B. Afeyan, Ph.D. (2) ×3 Einreichungen | 7. Juli 2022 | · | Erste Einreichung | · | SEC |
| Nestle Health Science US Holdings, Inc. (1), NIMCO US, Inc. (1), Nestlé S.A., Nestlé US Holdco, Inc. (1), Société des Produits Nestlé S.A. | 19. August 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 32 Insider · 16 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard N Kender | Interim Chief Executive Officer | 8. Juli 2026 A | 63.492 | 0 | 0 | $0 |
| Marella Thorell | EVP and Chief Financial Officer | 8. Juli 2026 A | · | 0 | 0 | $0 |
| David Arkowitz | Chief Financial Officer | 15. Februar 2024 M | 182.442 | 0 | 0 | $0 |
| Matthew R. Henn | President and Chief Scientific Officer | 15. August 2026 M | 7.995 | 0 | 4 | $-23.449 |
| Kelly Brady | EVP, Chief Operating Officer | 15. August 2026 M | 8.679 | 0 | 2 | $-735 |
| Thomas Desrosier | EVP and Chief Legal Officer | 15. August 2026 M | 8.117 | 0 | 4 | $-2.944 |
| Teresa L. Young | EVP, Chief Commercial & Strategy Officer | 15. Februar 2026 M | 8.557 | 0 | 2 | $-18.662 |
| Lisa Von Moltke | Executive Vice President and Chief Medical Officer | 15. Februar 2025 M | 39.875 | 0 | 0 | $0 |
| David S. Ege | Executive Vice President and Chief Technology Officer | 15. August 2024 M | 77.575 | 0 | 0 | $0 |
| Paula Cloghessy | Executive Vice President, Chief People Officer | 27. Oktober 2023 M | 45.684 | 0 | 0 | $0 |
| Marcus Chapman | SVP, Principal Financial and Accounting Officer | 4. Februar 2021 A | 8.600 | 0 | 0 | $0 |
| John G. Aunins | Chief Technology Officer & EVP | 29. Januar 2020 A | 105.250 | 0 | 0 | $0 |
| David N Cook | Chief Scientific Officer and EVP of R&D | 26. Januar 2019 M | 147.435 | 0 | 0 | $0 |
| Kevin Horgan | Chief Medical Officer and EVP | 25. Januar 2019 A | · | 0 | 0 | $0 |
| Michele Trucksis | Chief Medical Officer and EVP | 30. Januar 2018 A | 4.893 | 0 | 0 | $0 |
| Wael Hashad | EVP & Chief Commercial Officer | 26. Januar 2017 A | · | 0 | 0 | $0 |
| Eric D. Shaff | Direktor | 15. August 2026 M | 12.499 | 0 | 4 | $-9.095 |
| Stephen Berenson | Direktor | 8. Juli 2026 A | 3.589 | 0 | 0 | $0 |
| Robert L. Rosiello | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Kurt Graves | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Claire Fraser | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Dennis A Ausiello | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Willard H Dere | Direktor | 8. Juli 2026 A | 31.746 | 0 | 0 | $0 |
| Paul Biondi | Direktor | 10. April 2025 A | 47.619 | 0 | 0 | $0 |
| Hans-Juergen Woerle | Direktor | 4. Februar 2025 A | · | 0 | 0 | $0 |
| Gregory Behar | Direktor | 22. Juni 2023 A | · | 0 | 0 | $0 |
| Meryl Zausner | Direktor | 5. Juli 2022 A | 31.746 | 0 | 0 | $0 |
| AFEYAN NOUBAR | Direktor | 18. Juni 2019 P | 4.444.444 | 0 | 0 | $0 |
| Lorence H. Kim | Direktor | 13. Juni 2019 A | · | 0 | 0 | $0 |
| Roger Pomerantz | Direktor | 13. Juni 2019 A | 213.976 | 0 | 0 | $0 |
| Peter Barton Hutt | Direktor | 15. Juni 2016 A | · | 0 | 0 | $0 |
| Werner Cautreels | Direktor | 25. Juni 2015 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 4 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 25.222 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 12.603 SH | 2. Oktober 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 75.849 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 206.170 SH | 19. August 2026 | Täglich |
MCRB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$17.00
+478,2%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-03Mittelwert-Ziel $17.00 +478,2%
← Unter allen Zielen
Aktueller Preis $2.94
Tief$12.00
Mittelwert$17.00
Hoch$22.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MCRB | $142M | 23.2 | · | 721.9% | 14.8% | · |
| BYSI | · | · | · | · | 3.1% | · |
| ABVC | $53M | -5.5 | 234.3% | · | -128.2% | · |
| QNCX | $187M | -2.0 | · | · | 700.5% | · |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | · |
| RNAZ | · | -0.1 | · | · | · | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| GRDX | $20M | -1.1 | · | -17634.4% | -68.6% | -1813.6% |
| KYNB | $36M | 0.2 | -78.3% | 2848.6% | -143.5% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026